Cabot Corporation (NYSE:CBT) Receives Consensus Rating of “Hold” from Brokerages

Shares of Cabot Corporation (NYSE:CBT) have earned a consensus recommendation of “Hold” from the seven brokerages that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company. The average 1 year price target among analysts that have covered the stock in the last year is $83.80.

A number of analysts have recently weighed in on CBT shares. UBS Group raised their price objective on Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a research report on Friday, May 8th. Mizuho raised their price objective on Cabot from $75.00 to $80.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a research report on Tuesday, May 26th. JPMorgan Chase & Co. raised their price objective on Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a research report on Wednesday, May 13th. Finally, Truist Financial started coverage on Cabot in a research report on Monday, June 8th. They issued a “buy” rating and a $98.00 price objective for the company.

Cabot Stock Down 3.5%

Shares of NYSE CBT opened at $87.49 on Wednesday. The company has a current ratio of 1.45, a quick ratio of 0.96 and a debt-to-equity ratio of 0.51. The stock has a market capitalization of $4.52 billion, a PE ratio of 16.54, a price-to-earnings-growth ratio of 11.93 and a beta of 0.82. The stock’s fifty day simple moving average is $82.10 and its two-hundred day simple moving average is $75.22. Cabot has a 12-month low of $58.33 and a 12-month high of $93.15.

Cabot (NYSE:CBT) last announced its earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.47 by $0.14. The business had revenue of $904.00 million for the quarter, compared to analysts’ expectations of $900.31 million. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The business’s revenue for the quarter was down 3.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.90 EPS. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. As a group, analysts expect that Cabot will post 6.34 EPS for the current fiscal year.

Cabot Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 12th. Stockholders of record on Friday, May 29th were given a $0.4725 dividend. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend was Friday, May 29th. This is a positive change from Cabot’s previous quarterly dividend of $0.45. Cabot’s payout ratio is 35.73%.

Hedge Funds Weigh In On Cabot

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CBT. Norges Bank purchased a new position in Cabot in the 4th quarter worth $49,662,000. AQR Capital Management LLC raised its stake in Cabot by 123.0% in the 2nd quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock worth $65,096,000 after acquiring an additional 478,702 shares during the last quarter. UBS Group AG raised its stake in Cabot by 186.7% in the 3rd quarter. UBS Group AG now owns 593,510 shares of the specialty chemicals company’s stock worth $45,136,000 after acquiring an additional 386,514 shares during the last quarter. Pacer Advisors Inc. raised its stake in Cabot by 3,165.7% in the 4th quarter. Pacer Advisors Inc. now owns 229,252 shares of the specialty chemicals company’s stock worth $15,195,000 after acquiring an additional 222,232 shares during the last quarter. Finally, American Century Companies Inc. raised its stake in Cabot by 8.4% in the 3rd quarter. American Century Companies Inc. now owns 1,805,393 shares of the specialty chemicals company’s stock worth $137,300,000 after acquiring an additional 140,665 shares during the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.